Hiprex (Sanofi-Aventis U.S. LLC)
Welcome to the PulseAid listing for the Hiprex drug offered from Sanofi-Aventis U.S. LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sanofi-Aventis U.S. LLC |
| NON-PROPRIETARY NAME: | methenamine hippurate |
| SUBSTANCE NAME: | METHENAMINE HIPPURATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1976-09-09 |
| END MARKETING DATE: | 0000-00-00 |
Hiprex HUMAN PRESCRIPTION DRUG Details:
| Item Description | Hiprex from Sanofi-Aventis U.S. LLC |
| LABELER NAME: | Sanofi-Aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(g/1) |
| START MARKETING DATE: | 1976-09-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0068-0277_e5d36c00-3c13-49cf-a507-5e748cf35682 |
| PRODUCT NDC: | 0068-0277 |
| APPLICATION NUMBER: | NDA017681 |
Other METHENAMINE HIPPURATE Pharmaceutical Manufacturers / Labelers:
